news

Synoxyl® HSS Provides Photostability that Points the Way Formulating Safer & More Effective Sunscreens

The need to prevent skin from photo-damage caused by UV exposure is well-understood. However, the most effective way to achieve this is not. In a two-part series, published in the April and July 2018 issues of Cosmetics & Toiletries, Sytheon shared new learning that will assist cosmetic scientists in their quest to develop safer and more effective sunscreens for the US market.

Specifically, Synoxyl® HSS is a patented novel photostabilizer for Avobenzone and SPF booster that tested superior to key competitive benchmarks. Especially important, considering all the on-going safety and environmental concerns surrounding Octocrylene, Octinoxate and Oxybenzone, is the superior safety and biodegradability profile of Synoxyl® HSS.

The conclusions, drawn from in-vitro photostability and in-vivo SPF data, are that Synoxyl® HSS provides safe, eco-friendly and broad-spectrum skin protection (SPF 50+) when formulated into sunscreen sprays and emulsions [Chaudhuri, Ollengi, Singh & Martincigh, 3-(3,4,5-Trimethoxybenzilidene)-2,4-pentanedione: Design of a novel photostabilizer with in-vivo SPF boosting properties and its use in developing broad-spectrum sunscreen formulations, Int’ J Cosmet Sci, 39:25-35, 2017].

Synoxyl® HSS reduces the upstream oxidative stress cascade, presumably via the NADPH Oxidase pathway. Finally, a significant synergistic boost (75%) to the in-vivo SPF was observed using Synoxyl® HSS (2.5%) with the globally approved UV absorbers Avobenzone (3%), HMS (10%) and OS (5%).

For more information, please send your inquiry to info@sytheonltd.com

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Ratan K. Chaudhuri, Ph.D., President and CEO at Sytheon, will discuss key strategic targets for mitigating acne-affected skin. Sytheon, a...

by Drew FrantzenMay 19, 2023
Read More
Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic Anti-Inflammatory Effects of Isosorbide Fatty Acid Diesters in Cytokine-Induced Tissue Culture...

by hostingagencyusDecember 6, 2022
Read More
Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10 inspiring business leader by Inc. magazine to...

by hostingagencyusOctober 6, 2022
Read More
Sytenol® A is Accepted for Use in the Chinese Market

Sytenol® A is Accepted for Use in the Chinese Market

We are pleased to announce that Sytenol® A (Bakuchiol) has been successfully notified as a medium-low risk new cosmetic ingredient...

by hostingagencyusAugust 31, 2022
Read More
Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon relocates its headquarters to 10 Waterview Blvd, Parsippany, NJ. The move to a new state-of-the-art facility stems from Sytheon’s...

by hostingagencyusAugust 1, 2022
Read More
Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach for facial aging based on its multidirectional activity Beiersdorf...

by hostingagencyusJune 3, 2022
Read More